Novavax (NVAX) Files to Offer Up to $100M in Stock

Novavax (NASDAQ: NVAX) files prospectus supplement relates to the issuance and sale of up to $100,000,000 of our common stock from time to time through or to our sales agent, B. Riley FBR, Inc., or BRFBR

You May Also Be Interested In

• Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027
• CreeLED, Promeir Products resolve patent dispute via limited license agreement
• American Airlines announces Trump accounts matching program - CNBC